Case Reports
Improvement of Pretibial Myxedema Following Administration of Teprotumumab
November 2022 | Volume 21 | Issue 11 | Case Reports | 1252 | Copyright © November 2022
Pretibial myxedema (PTM) is a rare complication of Graves' disease. It is characterized by non-pitting edema with hyperpigmented hyperkeratotic papules and plaques on bilateral lower legs. Effective t...
Read MoreConcurrent Interstitial Granulomatous Dermatitis and TNF-α Antagonist-Induced Lupus Syndrome Secondary to Adalimumab for Crohn's Disease
November 2022 | Volume 21 | Issue 11 | Case Reports | 1256 | Copyright © November 2022
Tumor necrosis factor (TNF) antagonists have revolutionized management for various autoimmune and inflammatory conditions, including rheumatoid arthritis (RA), inflammatory bowel disease, hidradenitis...
Read MoreThe "Flolan Rash": An Impressively Asymptomatic and Non-Inflammatory Eruption Following Long-Term Epoprostenol Therapy
November 2022 | Volume 21 | Issue 11 | Case Reports | 1249 | Copyright © November 2022
Epoprostenol (Flolan) is a last-resort intravenous medication for the treatment of severe pulmonary arterial hypertension (PAH). Cutaneous adverse events of Flolan are well-known by pulmonologists, th...
Read MoreDermatomal Granulomatous Dermatitis and Vasculitis Following Herpes Zoster Ophthalmicus
October 2022 | Volume 21 | Issue 10 | Case Reports | 1127 | Copyright © October 2022
Cutaneous granulomatous dermatoses are uncommon sequelae of herpes zoster (HZ) infection that have been documented in the literature, with granulomatous vasculitis described in rare cases. Here, we re...
Read MoreWhy Does Facial Eczema Differ From Body Eczema?
October 2022 | Volume 21 | Issue 10 | Case Reports | 1119 | Copyright © October 2022
Background: The pathophysiology of atopic dermatitis (AD) is multifactorial, influenced by genetics, skin barrier dysfunction, and environmental stressors. There is a lack of research...
Read MoreLong-Term Efficacy and Safety of Omalizumab Monotherapy in a Patient With Normocomplementemic Urticarial Vasculitis
October 2022 | Volume 21 | Issue 10 | Case Reports | 1124 | Copyright © October 2022
Normocomplementemic urticarial vasculitis is a rare autoimmune disorder characterized by leukocytoclasia, fibrin deposits, and extravasated erythrocytes affecting multiple organ systems. Current treat...
Read MoreSevere Psoriasis Presenting in 3-Year-Old Child With Nail Dystrophy: Response to Biologic Treatment
August 2022 | Volume 21 | Issue 8 | Case Reports | 897 | Copyright © August 2022
Psoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of ...
Read MoreRituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid
August 2022 | Volume 21 | Issue 8 | Case Reports | 894 | Copyright © August 2022
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the sc...
Read MorePediatric Verrucous Psoriasis: A Case Report in a Pediatric Patient and Discussion of the Literature
August 2022 | Volume 21 | Issue 8 | Case Reports | 891 | Copyright © August 2022
Verrucous psoriasis (VP) is a rare histologic variant of psoriasis. To date, fewer than 40 cases have been reported, with pediatric cases representing an exceedingly small fraction. Treatment options ...
Read MoreReversible Hair Loss in Lichen Planopilaris: Regrowth With Low-Dose Naltrexone and Platelet-Rich Plasma
June 2022 | Volume 21 | Issue 6 | Case Reports | 671 | Copyright © June 2022
Lichen planopilaris (LPP) is a cicatricial alopecia that presents with patchy or diffuse hair loss at the vertex or parietal scalp. The literature has limited evidence on treatments for this challengi...
Read MoreSuccessful Outpatient Management of Diffuse Photosensitive Bullous Dermatitis Following Pembrolizumab Therapy
June 2022 | Volume 21 | Issue 6 | Case Reports | 668 | Copyright © June 2022
Immune checkpoint inhibitors including programmed death protein 1 inhibitors show great therapeutic benefit for numerous advanced malignancies but can cause a spectrum of immune-related adverse events...
Read MoreImprovement of Unilateral Breast Hypoplasia With Oral Spironolactone in a Patient With Becker Nevus Syndrome
April 2022 | Volume 21 | Issue 4 | Case Reports | 425 | Copyright © April 2022
Becker nevus (BN) is a benign cutaneous smooth muscle hamartoma that presents with a hyperpigmented patch or plaque with or without hypertrichosis.1 BN may be associated with ipsilateral br...
Read MoreA Case of Late-Onset Alopecia Areata
April 2022 | Volume 21 | Issue 4 | Case Reports | 420 | Copyright © April 2022
Alopecia areata (AA) is a condition characterized by nonscarring hair loss. Cases of alopecia areata are most commonly seen in patients under age 30 and are frequently idiopathic. In this report, we d...
Read MoreDeep Sweet Syndrome Secondary to Pegfilgrastim
April 2022 | Volume 21 | Issue 4 | Case Reports | 422 | Copyright © April 2022
Sweet syndrome, or acute febrile neutrophilic dermatosis, is a skin condition consisting of erythematous papules and plaques in association with fever, neutrophilia, and a neutrophilic infiltrate that...
Read MorePustular Psoriasis Appearing Induced by Dupilumab Therapy in a Patient With Atopic Dermatitis
March 2022 | Volume 21 | Issue 3 | Case Reports | 311 | Copyright © March 2022
Dupilumab inhibits T-helper 2 (Th2)-driven inflammation cascade by blocking interleukin-4 (IL-4) and IL-13 signaling, which has been recognized to play a crucial role in the pathogenesis of atopic der...
Read MoremTOR Inhibitor-Induced Transient Acantholytic Dermatitis
March 2022 | Volume 21 | Issue 3 | Case Reports | 315 | Copyright © March 2022
A 61-year-old Caucasian male with a medical history of metastatic carcinoid presented to dermatology with a new onset severely pruritic “breakouts” on the arms, neck, and chest. Approximat...
Read MoreAcne Information on Instagram: Quality of Content and the Role of Dermatologists on Social Media
March 2022 | Volume 21 | Issue 3 | Editorials | 333 | Copyright © March 2022
While it is evident that many patients turn to social media for information about skin care, the quality and content of available information are not well characterized. In this study, we investigated...
Read MoreSuccessful Treatment of Cheilitis Granulomatosa With Certolizumab and Ustekinumab
March 2022 | Volume 21 | Issue 3 | Case Reports | 317 | Copyright © March 2022
Cheilitis granulomatosa (CG) is a subtype of orofacial granulomatosis that results in facial and oral swelling in the absence of non-caseating granulomatous systemic diseases such as Crohn’s and...
Read MoreRefractory Dissecting Cellulitis of the Scalp Treated With Risankizumab
March 2022 | Volume 21 | Issue 3 | Case Reports | 313 | Copyright © March 2022
Perifolliculitis capitis abscedens et suffodiens or dissecting cellulitis (DC) is a rare and chronic disease with a predilection for the occipital, vertex, and parietal scalp. DC is characterized by m...
Read MorePlatelet Rich Plasma for the Treatment of Scarring Alopecia Due to Discoid Lupus Erythematosus
March 2022 | Volume 21 | Issue 3 | Case Reports | 309 | Copyright © March 2022
Platelet-rich plasma (PRP) is an autologous concentration of plasma from a patient’s blood containing platelets up to 7 times higher than normal plasma. Originally indicated to improve connectiv...
Read More